PULSE BIOSCIENCES, INC. — Director's Dealing 2020

Jun 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2020-06-15

Reporting Person: Zanganeh Maky (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-15	Common Stock	X	20000	$7.01	Acquired	352500	Direct
2020-06-15	Common Stock	X	2050	$7.01	Acquired	97624	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-15	Warrant (right to buy)	$7.01	P	3000	Acquired	2025-06-15	Common Stock (3000)	Direct
2020-06-15	Warrant (right to buy)	$7.01	P	307	Acquired	2025-06-15	Common Stock (307)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	27000	Indirect
Common Stock	14000	Indirect

Footnotes

F1: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC.